Sanjeev Narula
CIK 1820590 · Chief Financial & Bus. Officer · last filed 2026-01-02
Sanjeev Narula is a Chief Financial & Bus. Officer who has filed 15 SEC Form 4 insider transactions across 3 companies since 2020. The most recent filing, for PHAT, was dated Jan 2, 2026. Current disclosed insider exposure totals $3.2M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$3.21M
3
15
$0
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| PHAT | Chief Financial & Bus. Officer | 226,715 | $10.37 | $2.35M | $0 | 3 | 2026-01-02 |
| Intra-Cellular Therapies, Inc. (ITCI) Delisted | Executive Vice President & CFO | — | $131.87 | — | $0 | 3 | 2025-04-02 |
| VTRS | Chief Financial Officer | 52,006 | $16.48 | $857.1K | $0 | 9 | 2023-03-06 |
Recent Filings
15 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-01-02 | PHAT | Grant (A) | +82,715 | $0 | EDGAR |
| 2025-10-08 | PHAT | Grant (A) | +144,000 | $0 | EDGAR |
| 2025-10-07 | PHAT | Grant (A) | — | $0 | EDGAR |
| 2025-04-02 | Intra-Cellular Therapies, Inc. (ITCI) Delisted | Disp (D) | — | $0 | EDGAR |
| 2025-02-04 | Intra-Cellular Therapies, Inc. (ITCI) Delisted | Grant (A) | — | $0 | EDGAR |
| 2024-08-14 | Intra-Cellular Therapies, Inc. (ITCI) Delisted | Grant (A) | — | $0 | EDGAR |
| 2023-03-06 | VTRS | Mixed | +38,703 | -$331.4K | EDGAR |
| 2023-03-01 | VTRS | Mixed | +12,796 | -$112.0K | EDGAR |
| 2022-03-23 | VTRS | Grant (A) | — | $0 | EDGAR |
| 2022-03-04 | VTRS | Mixed | +15,064 | -$122.5K | EDGAR |